← Back to front page
United States · Platforms & data · MarketBeat

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened

Published by MarketBeat · United States 52 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Fidelis Insurance Holdings boosts dividend by 46.7% to $0.22 a share

 The Motley Fool

Is SpaceX Stock a Buy Before Its First Try at Catching a Starship Upper Stage?

 Investing.com

Earnings call transcript: Ströer Q3 2026 gains on digital ad growth and steady outlook

 MarketWatch

Jensen Huang built Nvidia into a behemoth. His scandal puts the entire AI boom in jeopardy.

 CNBC

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair

 TipRanks

SSAB Signs EUR 800 Million Revolving Credit Facility